326 related articles for article (PubMed ID: 32668817)
1. Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System.
Laudisi F; Marônek M; Di Grazia A; Monteleone G; Stolfi C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668817
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
3. Double Repositioning: Veterinary Antiparasitic to Human Anticancer.
Sultana T; Jan U; Lee JI
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457127
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects.
Nath J; Paul R; Ghosh SK; Paul J; Singha B; Debnath N
Life Sci; 2020 Oct; 258():118189. PubMed ID: 32781060
[TBL] [Abstract][Full Text] [Related]
5. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
6. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
7. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
Domalaon R; Okunnu O; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
[TBL] [Abstract][Full Text] [Related]
8. Anthelmintic resistance on an organized sheep farm in India.
Swarnkar CP; Sanyal PK; Singh D; Khan FA; Bhagwan PS
Trop Anim Health Prod; 2001 Jul; 33(4):305-12. PubMed ID: 11474864
[TBL] [Abstract][Full Text] [Related]
9. Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer.
Senkowski W; Zhang X; Olofsson MH; Isacson R; Höglund U; Gustafsson M; Nygren P; Linder S; Larsson R; Fryknäs M
Mol Cancer Ther; 2015 Jun; 14(6):1504-16. PubMed ID: 25911689
[TBL] [Abstract][Full Text] [Related]
10. Salicylanilides and Their Anticancer Properties.
Kauerová T; Pérez-Pérez MJ; Kollar P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675241
[TBL] [Abstract][Full Text] [Related]
11. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.
Tharmalingam N; Port J; Castillo D; Mylonakis E
Sci Rep; 2018 Feb; 8(1):3701. PubMed ID: 29487357
[TBL] [Abstract][Full Text] [Related]
12. Benzimidazole-carbamate anthelmintics: Perspective candidates for the anticancer drug development.
Prasher P; Sharma M
Drug Dev Res; 2022 Apr; 83(2):296-300. PubMed ID: 35297083
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic Drugs as Emerging Immune Modulators in Cancer.
Stolfi C; Pacifico T; Luiz-Ferreira A; Monteleone G; Laudisi F
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047419
[TBL] [Abstract][Full Text] [Related]
14. Computational repurposing of benzimidazole anthelmintic drugs as potential colchicine binding site inhibitors.
Khattab M; Al-Karmalawy AA
Future Med Chem; 2021 Oct; 13(19):1623-1638. PubMed ID: 34505541
[No Abstract] [Full Text] [Related]
15. Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.
Marrugal-Lorenzo JA; Serna-Gallego A; Berastegui-Cabrera J; Pachón J; Sánchez-Céspedes J
Sci Rep; 2019 Jan; 9(1):17. PubMed ID: 30626902
[TBL] [Abstract][Full Text] [Related]
16. Resistance of field strains of Haemonchus contortus to ivermectin, closantel, rafoxanide and the benzimidazoles in South Africa.
van Wyk JA; Malan FS
Vet Rec; 1988 Aug; 123(9):226-8. PubMed ID: 3176284
[TBL] [Abstract][Full Text] [Related]
17. Niclosamide, a Drug with Many (Re)purposes.
Kadri H; Lambourne OA; Mehellou Y
ChemMedChem; 2018 Jun; 13(11):1088-1091. PubMed ID: 29603892
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of halogenated salicylanilides and their anthelmintic use in animals.
Swan GE
J S Afr Vet Assoc; 1999 Jun; 70(2):61-70. PubMed ID: 10855824
[TBL] [Abstract][Full Text] [Related]
19. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
20. A perspective on the discovery of selected compounds with anthelmintic activity against the barber's pole worm-Where to from here?
Jiao Y; Preston S; Hofmann A; Taki A; Baell J; Chang BCH; Jabbar A; Gasser RB
Adv Parasitol; 2020; 108():1-45. PubMed ID: 32291083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
